Showing 1 - 20 results of 30 for search 'Josee M. Zijlstra', query time: 0.07s
Refine Results
-
1
-
2
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from D... by Jakoba J. Eertink, Martijn W. Heymans, Gerben J. C. Zwezerijnen, Josée M. Zijlstra, Henrica C. W. de Vet, Ronald Boellaard
Published 2022-09-01
Article -
3
Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Expe... by Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
Published 2024-04-01
Article -
4
P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity an... by Annelies Nijdam, Eline M.J. Lammers, Berthe M. P. Aleman, Josée. M. Zijlstra, Flora E. Van Leeuwen, On Behalf Of The Beter Consortium
Published 2022-10-01
Article -
5
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods by Maria C. Ferrández, Jakoba J. Eertink, Sandeep S. V. Golla, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Josée M. Zijlstra, Ronald Boellaard
Published 2022-07-01
Article -
6
T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies by Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Richard Greil, Alden Moccia, Josée. M. Zijlstra, Sylvia Hartmann, Carsten Kobe, Markus Dietlein, Andreas Engert, Peter Borchmann
Published 2022-10-01
Article -
7
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma. by Yvonne W S Jauw, Josée M Zijlstra, Daphne de Jong, Danielle J Vugts, Sonja Zweegman, Otto S Hoekstra, Guus A M S van Dongen, Marc C Huisman
Published 2017-01-01
Article -
8
P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands by Eline M.J. Lammers, Annelies Nijdam, Josée. M. Zijlstra, Cécile P.M. Janus, Roel J. De Weijer, Flora E. Van Leeuwen, Berthe M. P. Aleman, On Behalf Of The Beter Consortium
Published 2022-10-01
Article -
9
Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example by Marc C. Huisman, C. Willemien Menke-van der Houven van Oordt, Josée M. Zijlstra, Otto S. Hoekstra, Ronald Boellaard, Guus A. M. S. van Dongen, Dhaval K. Shah, Yvonne W. S. Jauw
Published 2021-08-01
Article -
10
Sensitivity of an AI method for [18F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols by Maria C. Ferrández, Sandeep S. V. Golla, Jakoba J. Eertink, Bart M. de Vries, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Louise Schilder, Martijn W. Heymans, Josée M. Zijlstra, Ronald Boellaard
Published 2023-09-01
Article -
11
Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study by Stefanie Slot, Cristina Lavini, Gerben J. C. Zwezerijnen, Bouke J. H. Boden, J. Tim Marcus, Marc C. Huisman, Maqsood Yaqub, Ellis Barbé, Mariëlle J. Wondergem, Josée M. Zijlstra, Sonja Zweegman, Pieter G. Raijmakers
Published 2023-02-01
Article -
12
P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP by Diana Al-Sarayfi, Mirian Brink, Martine E. D. Chamuleau, Rolf Brouwer, Roos van Rijn, Djamila Issa, Wendy Deenik, Gerwin Huls, Rogier Mous, Joost S.P. Vermaat, Josee M. Zijlstra, Tom van Meerten, Marcel Nijland
Published 2023-08-01
Article -
13
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma by Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann
Published 2017-12-01
Article -
14
Efficacy and cost-utility of the eHealth application ‘Oncokompas’, supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life a... by Anouk S. Schuit, Karen Holtmaat, Nienke Hooghiemstra, Femke Jansen, Birgit I. Lissenberg-Witte, Veerle M. H. Coupé, Myra E. van Linde, Annemarie Becker-Commissaris, Jaap C. Reijneveld, Josée M. Zijlstra, Dirkje W. Sommeijer, Simone E. J. Eerenstein, Irma M. Verdonck-de Leeuw
Published 2019-10-01
Article -
15
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET by Jessica E. Wijngaarden, Yvonne W. S. Jauw, Gerben J. C. Zwezerijnen, Berlinda J. de Wit-van der Veen, Daniëlle J. Vugts, Josée M. Zijlstra, Guus A. M. S. van Dongen, Ronald Boellaard, C. Willemien Menke-van der Houven van Oordt, Marc C. Huisman
Published 2024-02-01
Article -
16
Case report: XMEN disease: a patient with recurrent Hodgkin lymphoma and immune thrombocytopenia by Pieter F. de Groot, Arjan J. Kwakernaak, Arjan J. Kwakernaak, Ester M. M. van Leeuwen, Rosalina M. L. van Spaendonk, Evert-Jan Kooi, Daphne de Jong, Taco W. Kuijpers, Taco W. Kuijpers, Josée M. Zijlstra, Godelieve J. de Bree, Godelieve J. de Bree
Published 2023-11-01
Article -
17
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients by Maria C. Ferrández, Sandeep S. V. Golla, Jakoba J. Eertink, Bart M. de Vries, Pieternella J. Lugtenburg, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Henrica C. W. de Vet, PETRA, Josée M. Zijlstra, Ronald Boellaard
Published 2023-08-01
Article -
18
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma by Esther E. E. Drees, Julia Driessen, Gerben J. C. Zwezerijnen, Sandra A. W. M. Verkuijlen, Jakoba J. Eertink, Monique A. J. vanEijndhoven, Nils J. Groenewegen, Andrea Vallés‐Martí, Daphne deJong, Ronald Boellaard, Henrica C. W. deVet, Dirk M. Pegtel, Josée M. Zijlstra
Published 2022-08-01
Article -
19
P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind... by Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Published 2022-10-01
Article -
20
P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment by Adinda Mieras, Annelies Nijdam, Berthe M. P. Aleman, Laurien Daniels, Eva De Jongh, Cécile P.M. Janus, Stijn Krol, Bastiaan D.P. Ta, Francisca Ong, Dick Johan Van Spronsen, Ward Posthuma, Wouter J. Plattel, Rimke Oostvogels, Karijn Verschueren, Josée. M. Zijlstra, Flora E. Van Leeuwen
Published 2022-10-01
Article